Control of early theiler's murine encephalomyelitis virus replication in macrophages by interleukin-6 occurs in conjunction with STAT1 activation and nitric oxide production

Journal of Virology

Volumn 86, Issue 19, 2012, Pages 10841-10851

  Moore, Tyler C ^a   Bush, Katherine L ^c   Cody, Liz ^a,b   Brown, Deborah M ^a,b   Petro, Thomas M ^b,c  

^a UNIVERSITY OF NEBRASKA   (United States)

^b UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; IMMUNOGLOBULIN F(AB) FRAGMENT; INTERLEUKIN 12; INTERLEUKIN 23; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; STAT1 PROTEIN; STAT3 PROTEIN;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; FEMALE; MACROPHAGE; MOUSE; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; VIRUS IMMUNITY; VIRUS INFECTION; VIRUS REPLICATION;

ANIMALS; CELL LINE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; MICE; NITRIC OXIDE; RNA INTERFERENCE; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; THEILOVIRUS; VIRUS REPLICATION;

MUS; THEILER'S ENCEPHALOMYELITIS VIRUS;

EID: 84869037921     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01402-12     Document Type: Article

References (52)

1. Al-Salleeh F, Petro TM. 2007. TLR3 and TLR7 are involved in expression of IL-23 subunits while TLR3 but not TLR7 is involved in expression of IFN-beta by Theiler's virus-infected RAW264.7 cells. Microbes Infect. 9:1384-1392.
2. Andoh A, et al. 2002. Extracellular signal-regulated kinases 1 and 2 par-ticipate in interleukin-17 plus tumor necrosis factor-alpha-induced stabi-lization of interleukin-6 mRNA in human pancreatic myofibroblasts. Biochim. Biophys. Acta 1591:69-74.
3. Banerjee S, Narayanan K, Mizutani T, Makino S. 2002. Murine coro-navirus replication-induced p38 mitogen-activated protein kinase activa-tion promotes interleukin-6 production and virus replication in cultured cells. J. Virol. 76:5937-5948.
4. Cammarota M, Bevilaqua LR, Dunkley PR, Rostas JA. 2001. Angioten-sin II promotes the phosphorylation of cyclic AMP-responsive element binding protein (CREB) at Ser133 through an ERK1/2-dependent mech-anism. J. Neurochem. 79:1122-1128.
5. Clatch RJ, Miller SD, Metzner R, Dal Canto MC, Lipton HL. 1990. Monocytes/macrophages isolated from the mouse central nervous system contain infectious Theiler's murine encephalomyelitis virus (TMEV). Vi-rology 176:244-254.
6. Dhamija S, et al. 2011. Interleukin-1 activates synthesis of interleukin-6 by interfering with a KH-type splicing regulatory protein (KSRP)-dependent translational silencing mechanism. J. Biol. Chem. 286:33279-33288.
7. Dong C, Davis RJ, Flavell RA. 2002. MAP kinases in the immune re-sponse. Annu. Rev. Immunol. 20:55-72.
8. Droogmans L, Cludts I, Cleuter Y, Kettmann R, Burny A. 1992. Nu-cleotide sequence of the bovine interleukin-6 gene promoter. DNA Seq. 3:115-117.
9. Gadient RA, Otten U. 1994. Identification of interleukin-6 (IL-6)-expressing neurons in the cerebellum and hippocampus of normal adult rats. Neurosci. Lett. 182:243-246.
10. Grassl C, Luckow B, Schlondorff D, Dendorfer U. 1999. Transcriptional regulation of the interleukin-6 gene in mesangial cells. J. Am. Soc. Neph-rol. 10:1466-1477.
11. Hama T, Miyamoto M, Tsukui H, Nishio C, Hatanaka H. 1989. Inter-leukin-6 as a neurotrophic factor for promoting the survival of cultured basal forebrain cholinergic neurons from postnatal rats. Neurosci. Lett. 104:340-344.
12. Harker JA, Lewis GM, Mack L, Zuniga EI. 2011. Late interleukin-6 escalates T follicular helper cell responses and controls a chronic viral infection. Science 334:825-829.
13. Hemmann U, et al. 1996. Differential activation of acute phase response factor/Stat3 and Stat1 via the cytoplasmic domain of the interleukin 6 signal transducer gp130. J. Biol. Chem. 271:12999-13007.
14. Hou W, Kang HS, Kim BS. 2009. Th17 cells enhance viral persistence and inhibit T cell cytotoxicity in a model of chronic virus infection. J. Exp. Med. 206:313-328.
15. Hsieh CS, et al. 1993. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547-549.
16. Ishihara K, Hirano T. 2002. IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev. 13:357-368.
17. Jin Y-H, et al. 2007. Differential virus replication, cytokine production, and antigen-presenting function by microglia from susceptible and resis-tant mice infected with Theiler's virus. J. Virol. 81:11690-11702.
18. Kapil P, et al. 2009. Interleukin-12 (IL-12), but not IL-23, deficiency ameliorates viral encephalitis without affecting viral control. J. Virol. 83: 5978-5986.
19. Kim SH, Kim J, Sharma RP. 2004. Inhibition of p38 and ERK MAP kinases blocks endotoxin-induced nitric oxide production and differen-tially modulates cytokine expression. Pharmacol. Res. 49:433-439.
20. Kondadasula SV, et al. 2008. Colocalization of the IL-12 receptor and FcγRIIIa to natural killer cell lipid rafts leads to activation of ERK and enhanced production of interferon-γ. Blood 111:4173-4183.
21. Leonard M, Ryan MP, Watson AJ, Schramek H, Healy E. 1999. Role of MAP kinase pathways in mediating IL-6 production in human primary mesangial and proximal tubular cells. Kidney Int. 56:1366-1377.
22. Li X, Leung S, Qureshi S, Darnell JE, Jr, Stark GR. 1996. Formation of STAT1-STAT2 heterodimers and their role in the activation of IRF-1 gene transcription by interferon-alpha. J. Biol. Chem. 271:5790-5794.
23. Marie I, Durbin JE, Levy DE. 1998. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J. 17:6660-6669.
24. Mihara M, Hashizume M, Yoshida H, Suzuki M, Shiina M. 2011. IL-6/IL-6 receptor system and its role in physiological and pathological conditions. Clin. Sci. (Lond.) 122:143-159.
25. Monteyne P, Bihl F, Levillayer F, Brahic M, Bureau JF. 1999. The Th1/Th2 balance does not account for the difference of susceptibility of mouse strains to Theiler's virus persistent infection. J. Immunol. 162: 7330-7334.
26. Moore TC, Al-Salleeh FM, Brown DM, Petro TM. 2011. IRF3 polymor-phisms induce different innate anti-Theiler's virus immune responses in RAW264.7 macrophages. Virology 418:40-48.
27. Moore WM, et al. 1994. L-N6-(1-Iminoethyl)lysine: A selective inhibitor of inducible nitric oxide synthase. J. Med. Chem. 37:3886-3888.
28. Mott KR, Underhill D, Wechsler SL, Town T, Ghiasi H. 2009. A role for the JAK-STAT1 pathway in blocking replication of HSV-1 in dendritic cells and macrophages. Virol. J. 6:56.
29. Nishiya T, et al. 1997. Activation of Stat1 and subsequent transcription of inducible nitric oxide synthase gene in C6 glioma cells is independent of interferon-γ-induced MAPK activation that is mediated by p21ras. FEBS Lett. 408:33-38.
30. O'Gorman WE, et al. 2010. Alternate mechanisms of initial pattern rec-ognition drive differential immune responses to related poxviruses. Cell Host Microbe 8:174-185.
31. Oh YS, Lee Y-J, Park EY, Jun H-S. 2011. Interleukin-6 treatment induces beta-cell apoptosis via STAT-3-mediated nitric oxide production. Diabe-tes Metab. Res. Rev. 27:813-819.
32. Okuda Y, et al. 1998. IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligo-dendrocyte glycoprotein. Int. Immunol. 10:703-708.
33. Oleszak EL, Chang JR, Friedman H, Katsetos CD, Platsoucas CD. 2004. Theiler's virus infection: a model for multiple sclerosis. Clin. Microbiol. Rev. 17:174-207.
34. Palma JP, Kwon D, Clipstone NA, Kim BS. 2003. Infection with Theiler's murine encephalomyelitis virus directly induces proinflammatory cyto-kines in primary astrocytes via NF-{kappa}B activation: potential role for the initiation of demyelinating disease. J. Virol. 77:6322-6331.
35. Pavelko KD, et al. 2003. Interleukin-6 protects anterior horn neurons from lethal virus-induced injury. J. Neurosci. 23:481-492.
36. Persson E, Voznesensky OS, Huang YF, Lerner UH. 2005. Increased expression of interleukin-6 by vasoactive intestinal peptide is associated with regulation of CREB, AP-1 and C/EBP, but not NF-kappaB, in mouse calvarial osteoblasts. Bone 37:513-529.
37. Petro TM. 2005. Disparate expression of IL-12 by SJL/J and B10.S mac-rophages during Theiler's virus infection is associated with activity of TLR7 and mitogen-activated protein kinases. Microbes Infect. 7:224-232.
38. Petro TM. 2005. ERK-MAP-kinases differentially regulate expression of IL-23 p19 compared with p40 and IFN-beta in Theiler's virus-infected RAW264.7 cells. Immunol. Lett. 97:47-53.
39. Rodriguez M, Pavelko KD, McKinney CW, Leibowitz JL. 1994. Recom-binant human IL-6 suppresses demyelination in a viral model of multiple sclerosis. J. Immunol. 153:3811-3821.
40. Samoilova EB, Horton JL, Hilliard B, Liu T-ST, Chen Y. 1998. IL-6-deficient mice are resistant to experimental autoimmune encephalomy-elitis: roles of IL-6 in the activation and differentiation of autoreactive T cells. J. Immunol. 161:6480-6486.
41. Sanders SP, Siekierski ES, Porter JD, Richards SM, Proud D. 1998. Nitric oxide inhibits rhinovirus-induced cytokine production and viral replication in a human respiratory epithelial cell line. J. Virol. 72:934-942.
42. Sawada T, Falk LA, Rao P, Murphy WJ, Pluznik DH. 1997. IL-6 induction of protein-DNA complexes via a novel regulatory region of the inducible nitric oxide synthase gene promoter: role of octamer binding proteins. J. Immunol. 158:5267-5276.
43. Schobitz B, de Kloet ER, Sutanto W, Holsboer F. 1993. Cellular local-ization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain. Eur. J. Neurosci. 5:1426-1435.
44. Sehgal PB, et al. 1988. Regulation of the acute phase and immune re-sponses in viral disease. Enhanced expression of the beta 2-interferon/ hepatocyte-stimulating factor/interleukin 6 gene in virus-infected human fibroblasts. J. Exp. Med. 167:1951-1956.
45. Shaywitz AJ, Greenberg ME. 1999. CREB: a stimulus-induced transcrip-tion factor activated by a diverse array of extracellular signals. Annu. Rev. Biochem. 68:821-861.
46. Shresta S, et al. 2005. Critical roles for both STAT1-dependent and elitis: roles of IL-6 in the activation and differentiation of autoreactive T cells. J. Immunol. 161:6480-6486.
47. Spooren A, et al. 2011. Interleukin-6, a mental cytokine. Brain Res. Rev. 67:157-183.
48. Starnes HF, Jr, et al. 1990. Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-alpha challenge in mice. J. Immunol. 145:4185-4191.
49. Tuyt LM, et al. 1999. Extracellular-regulated kinase 1/2, Jun N-terminal kinase, and c-Jun are involved in NF-kappa B-dependent IL-6 expression in human monocytes. J. Immunol. 162:4893-4902.
50. Xu Z, et al. 2011. miR-365, a novel negative regulator of interleukin-6 gene expression, is cooperatively regulated by Sp1 and NF-kB. J. Biol. Chem. 286:21401-21412.
51. Zanassi P, et al. 2001. cAMP-dependent protein kinase induces cAMP-response element-binding protein phosphorylation via an intracellular calcium release/ERK-dependent pathway in striatal neurons. J. Biol. Chem. 276:11487-11495.
52. Zhang P-L, et al. 2006. Increased myelinating capacity of embryonic stem cell derived oligodendrocyte precursors after treatment by interleukin-6/ soluble interleukin-6 receptor fusion protein. Mol. Cell Neurosci. 31:387-398.